Location: Greenwich
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Greenwich
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra Phase 2 · Velocity Clinical Research, Providence (East Greenwich) · AbbVie · NCT06602479 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy Phase N/A · Coastal Eye Surgeons · Astellas Pharma Global Development, Inc. · NCT06779773 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · Alliance for Clinical Trials in Oncology · NCT06876714 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT05806515 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary Phase 3 · Coastal Eye Surgeons · Kodiak Sciences Inc · NCT06990399 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT05256225 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT04852887 SORE Study: Sitz Baths After Urogynecologic Reconstruction NA · Greenwich Hospital · Yale University · NCT07215780 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT06058377 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers Phase N/A · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT05987241 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT04205968 Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT06022939 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT05675410 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT02734537 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio Phase 3 · Gandelman Cardiology, PC · Amgen · NCT07136012 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT06616584 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic NA · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT03723928 Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT06475989 A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo Phase 3 · Incyte Corporation · NCT06548360 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT06422806 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT04267848 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT03937635 Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO- Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT07166406 Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Out Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT06050252 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer NA · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT04251052 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT06580314 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT05642572
Look up another city
Look up another condition